FindTrial
Sign In

To find out the effective volume of 0.25% ropivacaine(anaesthetic drug) by ultrasound guided nerve block for positioning of hip fracture patients before giving spinal anaesthesia.

Median effective volume of 0.25% ropivacaine for Suprainguinal Fascia Iliaca Compartment Block [FICB] for positioning of hip fracture patients prior to neuraxial blockade: A prospective dose estimation study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048553
Enrollment
30
Registered
2022-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M84- Disorder of continuity of bone Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: 0.25% Ropivacaine: To determine the median effective dose of 0.25% ropivacaine for suprainguinal fascia iliaca block for optimal positioning for neuraxial blockade in 50% of the patient

Sponsors

Dr Pradipta Kumar Behera
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with age above 18 years undergoing surgery for hip fracture under sub-arachnoid blockade 2) BMI:18-30 kg/m2 3) ASA physical status: I-III

Exclusion criteria

Exclusion criteria: 1) Allergy to local anaesthestics drugs. 2) Any contraindication to neuraxial blockade like local infection at site of injection, raised intacranial pressure, spine trauma. 3) Prothrombin Time INR greater than 1.5,Platelet count less than 75,000/cmm 4) Patient refusal to FICB/ neuraxial blockade. 5) Previous surgery in suprainguinal region. 6) Patient unable to understand the procedure.

Design outcomes

Primary

MeasureTime frame
To determine the median effective dose of 0.25% ropivacaine for suprainguinal fascia iliaca block for optimal positioning for neuraxial blockade in 50% of the patient (EV50) & 95% of patient (EV95) posted for hip fracture surgery.Timepoint: Block will be considered successful if we can achieve op-timal positioning for subarachnoid blockade within 30 minutes of blockade without needing to supplement with intravenous narcotics, supplemental block—

Secondary

MeasureTime frame
To evaluate the association of drug volume with: 1. The time taken to achieve adequate analgesia for optimal positioning 2. Time to first rescue analgesia after surgery 3. 24 hours postoperative analgesia requirement 4. Complication rate Timepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Pradipta Kumar Behera

All India Institute of Medical Science New Delhi

drbabitagupta@hotmail.com9818302776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026